Publications by authors named "Tinke A"

In the early stages of development of a new Active Pharmaceutical Ingredient (API), insufficient material quantity is available for addressing processing issues, and it is highly desirable to be able to assess processability issues using the smallest possible powder sample quantity. A good example is milling of new active pharmaceutical ingredients. For particle breakage that is sensitive to strain rate, impact testing is the most appropriate method.

View Article and Find Full Text PDF

Reconstituted parenteral solutions of three surface-active anti-infective small-molecule drugs and solutions of sodium dodecyl sulfate (SDS, a model surfactant) were studied to quantify the impact of sample preparation and handling on particle counts. Turbidimetry and light obscuration profiles were recorded as a function of agitation and shearing with and without the introduction of foam into the solutions. SDS solutions at concentrations above the critical micelle concentration (CMC) show significantly greater sensitivity to shear and foam presence than SDS solution below the CMC: Values of >10 μm particles increased 8 fold over control (an unsheared sample) in the micellar solution vs.

View Article and Find Full Text PDF

Though various attempts have been made in literature to model the particle size distribution of an active pharmaceutical ingredient (API) in function of the required release profile of the pharmaceutical product, so far one has not succeeded to develop a universal approach in the correlation of particle size distribution and in vitro dissolution data. In this publication, a new approach is presented on the use of particle size distribution data in the prediction of the in vitro dissolution profile of a suspension formulation. For this purpose, various theoretical experiments were done simply on paper and based on the Noyes-Whitney [A.

View Article and Find Full Text PDF

Immediate release direct compression tablet formulations require a strict control of the particle characteristics (i.e. particle size (distribution) and shape) of both the active pharmaceutical ingredient (API) and the excipients.

View Article and Find Full Text PDF

A liquid chromatography-tandem mass spectrometry method for the determination of idazoxan in human (heparin) plasma is presented, which was developed and validated using 500 microl of sample. Sample preparation consisted of the addition of fluoroidazoxan as the internal standard, extraction at alkaline conditions into tert.-butyl methyl ether, followed by centrifugation, evaporation of the solvent and reconstitution in methanol.

View Article and Find Full Text PDF

A method is described for the determination of pilocarpine and its degradation products isopilocarpine, pilocarpic acid and isopilocarpic acid in human plasma and urine. The method is based on a simple sample preparation step -- ultrafiltration for plasma and dilution for urine samples -- followed by a reversed-phase liquid chromatographic separation of the analytes and detection by means of tandem mass spectrometry. Parameters affecting the performance of these steps are discussed.

View Article and Find Full Text PDF

Pseudo-electrochromatography is a combination of liquid chromatography and an electromigration technique, especially directed at the separation of ionic compounds prior to mass spectrometric detection with a mobile phase composition compatible with mass spectrometry. The application of pseudo-electrochromatography to the separation of food colours and aromatic glucuronides is described. An example of selectivity tuning by applying voltages of differing polarity during the chromatographic run is given.

View Article and Find Full Text PDF